Astria Therapeutics Inc.
ATXS | NASDAQ
$12.58
$0 (0.00%)
At close: Jan 23, 2026, 4:00 PM ET
Market Data
Market Cap $718.13M
Enterprise Value $494.87M
Beta 0.02
Average Volume 1.07M
Shares Outstanding (Diluted) 58.01M
Shares Change YoY 2.69%
Institutional Ownership 99.27%
Exchange NASDAQ
ISIN US04635X1028
Price Performance
Price Change 1M -4.3%
Price Change 3M 1.5%
Price Change 6M 82.6%
Price Change YTD -4.3%
Price Change 1Y 60.0%
Price Change 3Y -11.8%
Price Change 5Y -36.5%
1M CAGR (ann.) -2.9%
1Y CAGR (ann.) 67.7%
5Y CAGR (ann.) -4.3%
All-Time CAGR -32.3%
Valuation
PE Ratio -5.85
Forward PE N/A
PEG Ratio 0.90
Forward PEG 1.01
PS Ratio 1,017.18
Forward PS 76.00
PB Ratio 3.08
P/FCF Ratio -5.97
P/Adj. FCF Ratio -5.44
P/OCF Ratio -7.15
EV/Sales 700.94
EV/EBIT -3.69
EV/EBITDA -3.69
EV/FCF -4.11
Earnings Yield -17.1%
FCF Yield -16.8%
Adj. FCF Yield -18.4%
Financial Health
Net Cash $227.72M
Total Debt $4.46M
Cash & Short-Term Investments $227.72M
Total Assets $271.87M
Current Ratio 10.78
Quick Ratio 10.78
Debt / Equity Ratio 0.02
Debt / EBITDA -0.03
Debt / FCF -0.04
OCF / Debt -26.85
Interest Coverage 0.00
Altman Z-Score 6.57
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -19335.7%
EBITDA Margin -13938.2%
Net Profit Margin -13938.2%
FCF Margin -17042.9%
Adj. FCF Margin -18685.0%
SBC / Revenue 1770.3%
SBC Impact (per share) -9.6%
Returns
Return on Assets -36.2%
Return on Equity -37.7%
Return on Invested Capital -42.8%
Return on Capital Employed -43.0%
Return on Tangible Assets -36.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 150.0%
Revenue CAGR 5Y 100.0%
Revenue CAGR 10Y 16.9%
EPS CAGR 3Y -0.2%
EPS CAGR 5Y 81.0%
EPS CAGR 10Y 34.8%
FCF CAGR 3Y -40.6%
FCF CAGR 5Y -34.6%
FCF CAGR 10Y -17.7%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 8
EPS Growth Next 3Y 67.3%
Revenue Growth Next 3Y 730.7%
Earnings Date Nov 11, 2025
EPS Estimate (next Q) -$0.41
EPS Growth Est (next Q) -2.4%
Revenue Est (next Q) $10.67M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $19.40
Price Target Upside 54.2%
Cash Flow
Operating Cash Flow $-119.73M
Free Cash Flow $-120.32M
Adj. Free Cash Flow $-131.92M
FCF Per Share -$1.78
OCF Per Share -$1.76
OCF/S Ratio -14500.1%
Income Statement
Revenue $706K
Gross Profit $706K
Operating Income $-136.51M
EBITDA $-134.05M
Net Income $-124.03M
EPS (Diluted) -$2.15
Revenue / Employee $9.05K
Profit / Employee $-1.59M
Employees 78
Add to Watchlist
Select watchlists to add or remove ATXS